Evidence map›Paper›PMID 27208120›Full record

Trial reportApplied and environmental microbiology2016

Fermented Milk Containing Lactobacillus casei Strain Shirota Preserves the Diversity of the Gut Microbiota and Relieves Abdominal Dysfunction in Healthy Medical Students Exposed to Academic Stress.

Akito Kato-Kataoka, Kensei Nishida, Mai Takada, Mitsuhisa Kawai, Hiroko Kikuchi-Hayakawa, Kazunori Suda, Hiroshi Ishikawa, Yusuke Gondo, Kensuke Shimizu, Takahiro Matsuki and 7 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Applied and environmental microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 14 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 14 syntheses or guidelines pooled it, 273 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Trial
  16. Trial
  17. Trial
  18. Effects of Heat-TreatedNutrients · 2024
    Trial
  19. Novel probiotic preparation withMicrobiology spectrum · 2024
    Trial
  20. Nutrients · 2024
    Trial

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Akito Kato-KataokaYakult Central Institute, Izumi, Kunitachi, Tokyo, Japan.
Kensei NishidaDepartment of Pathophysiology, Institute of Biomedical Sciences, Tokushima University Graduate School, Kuramoto, Tokushima, Japan.
Mai TakadaYakult Central Institute, Izumi, Kunitachi, Tokyo, Japan.
Mitsuhisa KawaiYakult Central Institute, Izumi, Kunitachi, Tokyo, Japan.
Hiroko Kikuchi-HayakawaYakult Central Institute, Izumi, Kunitachi, Tokyo, Japan.
Kazunori SudaYakult Central Institute, Izumi, Kunitachi, Tokyo, Japan.
Hiroshi IshikawaYakult Central Institute, Izumi, Kunitachi, Tokyo, Japan.
Yusuke GondoYakult Central Institute, Izumi, Kunitachi, Tokyo, Japan.
Kensuke ShimizuYakult Central Institute, Izumi, Kunitachi, Tokyo, Japan.
Takahiro MatsukiYakult Central Institute, Izumi, Kunitachi, Tokyo, Japan.
Akira KushiroYakult Central Institute, Izumi, Kunitachi, Tokyo, Japan.
Ryoutaro HoshiDevelopment Department, Yakult Honsha Co., Ltd., Higashi-Shimbashi, Minato, Tokyo, Japan.
Osamu WatanabeDevelopment Department, Yakult Honsha Co., Ltd., Higashi-Shimbashi, Minato, Tokyo, Japan.
Tomoki IgarashiDevelopment Department, Yakult Honsha Co., Ltd., Higashi-Shimbashi, Minato, Tokyo, Japan.
Kouji MiyazakiYakult Central Institute, Izumi, Kunitachi, Tokyo, Japan koji-miyazaki@yakult.co.jp.ORCID 0000-0001-7489-6514
Yuki KuwanoDepartment of Pathophysiology, Institute of Biomedical Sciences, Tokushima University Graduate School, Kuramoto, Tokushima, Japan.
Kazuhito RokutanDepartment of Pathophysiology, Institute of Biomedical Sciences, Tokushima University Graduate School, Kuramoto, Tokushima, Japan.
Yakult Central Institute · JPTokushima University · JPYakult Honsha (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledStress-induced abdominal dysfunction is an attractive target for probiotics. To investigate the effects of the probiotic Lactobacillus casei strain Shirota on abdominal dysfunction, a double-blind, placebo-controlled trial was conducted with healthy medical students undertaking an authorized nationwide examination for academic advancement. For 8 weeks, until the day before the examination, 23 and 24 subjects consumed an L. casei strain Shirota-fermented milk and a placebo milk daily, respectively. In addition to assessments of abdominal symptoms, psychophysical state, and salivary stress markers, gene expression changes in peripheral blood leukocytes and composition of the gut microbiota were analyzed using DNA microarray analysis and 16S rRNA gene amplicon sequence analysis, respectively, before and after the intervention. Stress-induced increases in a visual analog scale measuring feelings of stress, the total score of abdominal dysfunction, and the number of genes with changes in expression of more than 2-fold in leukocytes were significantly suppressed in the L. casei strain Shirota group compared with those in the placebo group. A significant increase in salivary cortisol levels before the examination was observed only in the placebo group. The administration of L. casei strain Shirota, but not placebo, significantly reduced gastrointestinal symptoms. Moreover, 16S rRNA gene amplicon sequencing demonstrated that the L. casei strain Shirota group had significantly higher numbers of species, a marker of the alpha-diversity index, in their gut microbiota and a significantly lower percentage of Bacteroidaceae than the placebo group. Our findings indicate that the daily consumption of probiotics, such as L. casei strain Shirota, preserves the diversity of the gut microbiota and may relieve stress-associated responses of abdominal dysfunction in healthy subjects exposed to stressful situations. IMPORTANCE: A novel clinical trial was conducted with healthy medical students under examination stress conditions. It was demonstrated that the daily consumption of lactic acid bacteria provided health benefits to prevent the onset of stress-associated abdominal symptoms and a good change of gut microbiota in healthy medical students.

Indexed as

Stress, PhysiologicalAdultAnimalsBiotaCluster AnalysisDNA, BacterialDNA, RibosomalDouble-Blind MethodFemaleFermentationGastrointestinal TractHumansLacticaseibacillus caseiMaleMilkPhylogenyDNA, BacterialDNA, RibosomalPlacebosRNA, Ribosomal, 16S

Identifiers

PMID27208120
PMCPMC4959178
OpenAlexW2345497697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.